Cite
HARVARD Citation
Jimeno, A. et al. (n.d.). A first-in-man phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody OMP-305B83 in patients with previously treated solid tumors. European journal of cancer. pp. S35-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jimeno, A. et al. (n.d.). A first-in-man phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody OMP-305B83 in patients with previously treated solid tumors. European journal of cancer. pp. S35-. [Online].